The distribution of FK506 nanoparticles in rabbit eyes

Chinese Ophthalmic Research

Volumn 22, Issue 2, 2004, Pages 164-166

  Fei, Wenlei ^a   Chen, Jiaqi ^a   Pang, Zhiqing ^a   Quan, Daping ^a   Chen, Qingquan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Drug delivery system; Eye drops; FK506; Nanoparticles; Pharmacokinetics

Indexed keywords

EYE DROPS; NANOPARTICLE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; RABBIT; SCLERA;

EID: 2442501695     PISSN: 10030808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Hatanaka H, Kino T, Miyata S, et al, FR-900520 and FR-900523, novel immunosuppressants isolated from a streptomyces II. Fermantation, isolation and physico-chemical and biological characteristics[J]. Antibiot, 1988, 11:1592-1601
2. Pleyer U, Lutz S, Jusko WJ, et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye[J]. Invest Ophthalmol Vis Sci, 1993, 34(8):2737-2742
3. Quintanar-Guarrero D. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymer[J]. Drug Develop Indust Pharm, 1998, 25(12):1115-1123
4. Joshi A. Microparticulates of ophthalmic drug delivery[J]. J Ocul Pharmacol, 1994, 10(1):29-45
5. Kimura H, Ogura Y. Biodegradable polymers for ocular drug delivery[J]. Ophthalmologica, 2001, 215(3):143-155